The percentage of DNAM1+ and CD96+ NK cells is significantly lower in pancreatic cancer patients than in healthy controls, and reduced percentages of DNAM1+ and CD96+ NK cells are associated with tumor histologic grade and lymph node metastasis (118). Here, CD96 is linked to pancreatic neoplasm.